NKGen Biotech (NKGNW) Short Interest Ratio & Short Volume $0.04 -0.01 (-12.89%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends NKGen Biotech Short Interest DataNKGen Biotech (NKGNW) has a short interest of 16,500 shares. This marks a -4.62% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.8, indicating that it would take 1.8 days of the average trading volume of 17,182 shares to cover all short positions.Current Short Interest16,500 sharesPrevious Short Interest17,300 sharesChange Vs. Previous Month-4.62%Dollar Volume Sold Short$1,041.15Short Interest Ratio1.8 Days to CoverLast Record DateNovember 30, 2024Today's Trading Volume129,415 sharesAverage Trading Volume17,182 sharesToday's Volume Vs. Average753% Short Selling NKGen Biotech? Sign up to receive the latest short interest report for NKGen Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNKGNW Short Interest Over TimeNKGNW Days to Cover Over TimeNKGNW Percentage of Float Shorted Over Time Ad Crypto 101 MediaThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW NKGen Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202416,500 shares $1,041.15 -4.6%N/A1.8 $0.06 11/15/202417,300 shares $1,418.60 -10.8%N/A2.1 $0.08 10/31/202419,400 shares $611.10 +1,193.3%N/A2.4 $0.03 10/15/20241,500 shares $39.30 -89.0%N/A0.2 $0.03 9/30/202413,600 shares $961.52 -4.2%N/A2 $0.07 9/15/202414,200 shares $1,174.87 -25.3%N/A3.6 $0.08 8/31/202419,000 shares $2,517.50 -2.1%N/A5.9 $0.13 8/15/202419,400 shares $2,553.04 -5.8%N/A7.5 $0.13 7/31/202420,600 shares $1,891.08 -16.3%N/A3.6 $0.09 7/15/202424,600 shares $2,435.40 No ChangeN/A3.7 $0.10 2/15/20241,800 shares $46.80 -14.3%N/A0.5 $0.03 1/31/20242,100 shares $84.00 No ChangeN/A0.5 $0.04 NKGNW Short Interest - Frequently Asked Questions What is NKGen Biotech's current short interest? Short interest is the volume of NKGen Biotech shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 16,500 shares of NKGNW short. Learn More on NKGen Biotech's current short interest. What is a good short interest ratio for NKGen Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NKGNW shares currently have a short interest ratio of 2.0. Learn More on NKGen Biotech's short interest ratio. Is NKGen Biotech's short interest increasing or decreasing? NKGen Biotech saw a decline in short interest during the month of November. As of November 30th, there was short interest totaling 16,500 shares, a decline of 4.6% from the previous total of 17,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short NKGen Biotech stock? Short selling NKGNW is an investing strategy that aims to generate trading profit from NKGen Biotech as its price is falling. NKGNW shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NKGen Biotech? A short squeeze for NKGen Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NKGNW, which in turn drives the price of the stock up even further. How often is NKGen Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NKGNW, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies 180 Life Sciences Short Squeeze Alpha Tau Medical Short Squeeze Anew Medical Short Squeeze Apollomics Short Squeeze BriaCell Therapeutics Short Squeeze Cardio Diagnostics Short Squeeze Celularity Short Squeeze CERo Therapeutics Short Squeeze Clene Short Squeeze Conduit Pharmaceuticals Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NKGNW) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NKGen Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NKGen Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.